Targeted SSTR2 Program(Full Life Technologies)

N/A

Report date: 2025/11/24 17:31:59

Base Information

Drug NameTargeted SSTR2 Program(Full Life Technologies)

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionSomatostatin receptor 2 modulators

TargetsSomatostatin receptor 2

Therapy Area/IndicationsSmall Cell Lung CarcinomaNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFull Life Technologies Ltd

China Registration ClassN/A

Develop Information

Active CompaniesFull Life Technologies Ltd

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung CarcinomaNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A